Healthcare Analytical Testing Services Market To Grow Fastest in the APAC

The size of the healthcare analytical testing services market was USD 7,240.1 million in 2023, and it will power at a compound annual growth rate of 11.5% by the end of this decade, to touch  a value of USD 15,390.5 million by 2030. 

This growth has a lot to do with the growing count of subcontracting actions of analytical testing services by some pharma companies. Furthermore, the rising count of clinical trials that include analytical testing, the growing requirement for drugs and therapeutics, and the increasing importance on biosimilars are other factors pushing the growth of the industry.

The bioanalytical testing services category held a major revenue share, of around 25%, in 2023. This is due to the accessibility of extensive bioanalytical testing services for a wider range of drug types, such as small molecules, biologics, and vaccines, and several drug manufacturers are constantly working to produce more reliable healthcare analytical procedures that are accurate and efficient.

Furthermore, the higher requirement for the newest bioanalytical testing services is observed by contract producers. Apart from that, large firms are reviving their pipelines by investing in research and development departments, and because of the growing difficulty of these testing services, companies are compliant with the norms and rules levied on them. 

Therefore, these factors are powering the requirement for healthcare analytical testing services. Likewise, the molecule bioanalytical requirement is on the rise, owing to the growing investments in amino acid production-based molecules and biological drugs.

Furthermore, the use of cell-based assays in bioanalytical testing services is resulting in high requirements for this kind of service. These cell-based assays are widely employed in high-throughput screening due to their competence in offering valuable in-vivo biological info that thus bustles the drug discovery procedure.

North America is the leader of the healthcare analytical testing services market, with manufacturers providing testing instruments along with high-end pharma materials, tech progressions, and collaborations amongst industry players to advance cutting-edge healthcare solutions.

APAC will power at the fastest rate of 12% in the years to come. This growth has a lot to do with the increasing investments by foreign corporations for the development of cutting-edge facilities and associations to increase the reach of their products and services to diverse locations, and enhancements done by governing bodies for varying standards of assessment to line up with the international standards in the region.

It is because of the acceptance of novel techniques all over the world, that the demand for healthcare analytical testing services is on the rise. This trend will continue in the years to come as well.

Read More

Imaging Chemicals Market Will Touch USD 47.0 Billion in 2030

The imaging chemicals market was USD 31.7 billion in 2023, which will touch USD 47.0 billion, with a 5.8% compound annual growth rate, by 2030.

The growth of this industry is primarily because of the different uses of these chemicals like packaging, printing, textiles, and medical diagnostics.

The growing occurrence of brain disorders, cancer, and various other illnesses boosts the need for diagnostic imaging tests, including magnetic resonance imaging, computed tomography, and X-rays. 

Furthermore, the growing acceptance of digital printing, as it is quicker and more effective compared to traditional processes, is further boosting this category expansion. The acceptance of digital printing is also rising because of the shifting customer demands.

The printing & packaging category, based on application, was the largest contributor to the imaging chemicals market. This is because of the growing need for printing and packaging across the globe. Therefore, the surging need for the different chemicals utilized for this purpose makes the industry competitive.

Therefore, the growing occurrence of chronic illnesses that need radiological studies will boost this industry during this decade.

North America was the largest contributor to the industry in 2023, with a 45% share. This can be ascribed to the existence of highly developed healthcare infrastructure in this continent, as well as the increasing customer spending on healthcare. 

In addition, the U.S. was a significant contributor to the North American industry. This is because of the use of developed healthcare technologies in this country, coupled with the rising research activities in the continent.

With the rising application of these chemicals across different sectors, the imaging chemicals industry will continuously advance in the years to come.

Read More

Patient Registry Software Market Will Reach USD 5,638.3 Million By 2030

The value of the patient registry software market stood at USD 2,091.0 million in 2023, and this number is projected to reach USD 5,638.3 million by 2030, advancing at a CAGR of 15.3% during the projection period. The need for integrated registries is being boosted by the increasing occurrence of chronic illnesses, like diabetes, cancer, and cardiovascular illnesses,and the growing acceptance of electronic health records.

In 2023, the disease registry category generated the highest revenue, of USD 1.1 billion. Patients going through certain illnesses are registered in these registries. The leading share of this category is because of the elderly populace, surge in chronic and novel & uncommon illness occurrence, development in the understanding of the position of registries in health management, and extensive acceptance of EHRs.

 Illness registries are becoming more helpful as new ones provide historically comparable information and permit long-term assessment. Their acceptance is also being boosted by the increasing government efforts to make and handle patient health records at lesser prices and growing awareness of how to gather and use patients’ health data.

An electronic health record is a digitally stored, systematized collection of health information for patients and the general population. The sharing of such data is possible, by means of other information systems and exchanges including those that are network-connected or enterprise-wide IT systems, between different healthcare facilities. 

Electronic health records might comprise a range of information, like demographics, billing information, prescription, medical history and allergy data, radiological pictures, immunization status, laboratory test results, and data on vital signs.

Because of its user-friendly tools and sophisticated features, standalone software has a larger industry share. Standalone software covers rare diseases, cancer, cardiovascular disease, diabetes, and patient details. As a result, the data is accessible and extremely comprehensive.

During the projection period, the integrated category is projected to experience quicker expansion. An integrated system is an assembly of software utilized to screen the places impacted by an illness and measure the efficiency of clinical involvement. It also aids in learning more regarding illness occurrence and the effectiveness of treatment choices. Several modules of integrated software offer an extensive variety of functionalities not typically seen in standalone applications.

A defined group of people's clinical health results are advanced by better care management and patient participation, which are backed by appropriate financial and care models. This procedure is known as populace health management.

North America is the largest contributor to the industry in 2023. This can be ascribed to the increasing target population, growing need for population-based registries, and surging prevalence of diseases in this region. Moreover, the increasing government activities to promote the acceptance of these solutions make the continent a major user of these programs.

Read More

Hypervisor Market was Led by the APAC Region

 The revenue of the automotive hypervisor market was USD 218.1 million in 2023, and it will reach USD 1,168.3 million by 2030, proceeding at a rate of 27.2% by the end of this decade. 

The main factors powering the growth of the industry are the increasing requirement for autonomous and connected vehicles, growing pace of progression in EVs, surging consciousness of passenger and safety of the vehicles, and developing user interfaces and infotainment.

On the basis of the automation level, the semi-autonomous category will have a larger share in the years to come. This will be for the reason that consumers are becoming interested in automobiles with cutting-edge driver-assistance features and seeking a balance amid convenience, safety, and the driving experience. 

Also, the growing telecom & IT infra, improving living standards, and increasing count of upper-class individuals are driving the growth of this category.

Furthermore, they have powerful engines and cutting-edge suspension systems, which require sophisticated software management. The hypervisor tech helps enhance the coordination amid numerous systems in luxury cars, to offer optimal performance.

Also, because of the existence of top automotive companies, for example Mercedes-Benz, Audi, and BMW, in the U.S. and Germany, this category will grow in these nations. Moreover, the increasing sales of luxury vehicles and the growing requirement for automated systems in these vehicles powers the market growth in the nation.

APAC led the hypervisor market, with a share of 55%, in 2023, and it will grow at the fastest rate. The rising per capita income in developing economies, for example India and China, has augmented the customer’s purchasing power, which will power the passenger car sales. 

Along with this this, the region has some of the world’s largest automotive manufacturers and component suppliers. This manufacturing strength lets for the quick acceptance of new tech in numerous vehicle brands and models. 

Also, the easy obtainability of labor at a low cost for vehicle’s mass production has brought about the formation of several manufacturing plants. Furthermore, the advent of local players with state-of-the-art models in emerging markets will power the industry growth. 

Read More

BEV category is the Leader of the Electric Powertrain Market

The electric powertrain market was USD 95.9 billion in 2023, and it will propel at a rate of 13.1% by the end of this decade, to reach a total value of USD 226.3 billion by 2030. The growing requirement for e-vehicles and the numerous government initiatives taken at the global level for GHG emission reduction are a few key forces powering the expansion of the industry.

The battery category, under the component segment, is likely to dominate the market and grow at a CAGR of 13.0% during the projection period. 

The battery is among the major components of e-vehicles and has a substantial weightage. Therefore, the increase in the requirement for EVs will power the generation of revenue from traction battery sales. 

Moreover, there are different batteries for EVs, for instance, nickel–metal hydride batteries, lead–acid batteries, lithium-ion batteries, and ultracapacitors, amongst which lithium-ion batteries are increasingly common. Upon driving, this discharge, and then, the automobile is plugged into a charging station. Vehicle manufacturers offer a battery warranty, with regards to miles or years. 

Moreover, North American companies are investing to introduce plants for cathode manufacturing, to guarantee a smooth supply chain for EV batteries.

Numerous legislations are there at a global level with regards to environmental safety. For example, in India, the norms of Corporate Average Fuel Efficiency mandate that for each auto manufacturer, carbon emissions should be lower than 130 g/km till 2022 and less than 113 g/km after 2022.

The BEV category led the electric powertrain market, and it will advance at a rate of 13.2% in the future. This has a lot to do with the fact that these variants bring about a considerable reduction in emissions of carbon and, hence, obtain the sturdiest policy and financial assistance from the governments. 

There are no engines in BEVs and, the power on rechargeable batteries, thus producing negligible-to-no quantities of GHG and other air pollutants. Therefore, they are an efficient and clean means of transport with the added benefit of negligible-to-no noise pollution.

To ensure substantial infiltration of these environment-friendly automobiles, governments are taking more than a few initiatives, for example spreading consciousness, offering tax benefits, and advancing the charging infra. This is done so that users can avoid any sort of issue due to inaccessibility of charging stations, and depleted battery while traveling long distances.

It is because of the increasing requirement for EVs and associated infra of the world, that the demand for electric powertrains is on the rise. This trend will continue to grow in the years to come as well.

Read More

Medical Equipment Maintenance Market is Driven by Developments in Medical Devices

The medical equipment maintenance market was USD 48.9 billion in 2023, and it will touch USD 98.9 billion, powering at a 10.7% compound annual growth rate, by 2030.

To learn more about this report: 

The growth in this industry is because of the enhancements in medical devices, increasing consciousness regarding preventive maintenance, and strict regulatory environments all over the world.

The imaging category, on the basis of type, will lead the industry throughout this decade. This can be mainly because of the extensive utilization of imaging equipment for different medical conditions, such as neurological disorders and cancer.

The preventive and predictive category, on the basis of service type, is likely to propel at the fastest compound annual growth rate, in the years to come. This can be mainly because of the extensive range of services provided by service providers in the category, which produces huge expense savings for public- and private-sector establishments.

North America was the largest contributor to the industry in 2023, and it will remain leading in the years to come. This can be mainly because of the surging aging populace, increasing burden of ailment, growing acceptance of medical imaging systems, and rising count of hospitals.

Asia-Pacific is likely to observe the highest compound annual growth rate in the years to come. The key factors boosting this progression would be the surging incidence of chronic illnesses that need medical devices for early diagnosis and the rising count of diagnostic tests conducted in this region.

It is because of the continuous progression of medical devices, the medical equipment maintenance industry will continue to progress in the years to come.

Read More

Transplant Diagnostics Market was Led by the Molecular Assays Category

The transplant diagnostics market was valued at USD 4,686.7 million in 2023, and it will grow at a rate of 7.5% by the end of this decade, to touch USD 7,713.5 million by 2030.

To learn more about this report: https://bit.ly/3vek5es

This is attributable to the growing requirement for organ replacement procedures, the growing requirement for diagnostic procedures before organ replacement, and the powering occurrence of communicable diseases. 

Also, the number of people with final-stage organ failure is on the rise, and because of the development in organ transplantation procedures, a high number of patients can now access these surgeries.

On the basis of technology, molecular assay led the industry with a share, of 65%, in 2023, and it will continue to dominate in the future as well.

The diagnostics category dominated the transplant diagnostics market, with a share of 70%, in 2023, and it will continue like this in the future. This is credited to the increasing occurrence of ailments.

Furthermore, the diagnostic category is divided into pre-transplantation and post-transplantation diagnostic. Additionally, for transplant processes, all relative diagnostic tests will be done prior to the transplant to see the compatibility of the transplant for example blood profiling, histocompatibility testing, and communicable disease testing.

North America had the largest share, of 50%, in 2023, and it will continue like this in the future. This has a lot to do with the high acceptance rate of cutting-edge techniques and analytic tools, high healthcare spending, the obtainability of skilled experts, and the extensive use of soft tissue transplants, stem cell therapies, and tailored medications.

Furthermore, the growing count of organ replacements, the increasing consciousness of transplantation, the growing incidence of communicable ailments, and the rising elderly populace susceptible to chronic ailments are powering the industry.

There is an increasing number of organ transplants happening around the world, and this will power the demand for transplant diagnostic solutions. The trend will continue in the years to come as well.

Read More